# A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-iii-randomised-controlled-trial-of-erlotinib-vs-gefitinib-in-advanced/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jin‐Ji Yang,Qing Zhou,Hong‐Hong Yan,X C Zhang,H J Chen,Hai‐Yan Tu,Z Wang,Chong‐Rui Xu,Jian Su,Banglu Wang,Bo Jiang,Xiaoyan Bai,Wen‐Zhao Zhong,Xue‐Ning Yang,Yi‐Long Wu |
| Citations | 174 |
| DOI | 10.1038/bjc.2016.456 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/bjc2016456.pdf |
| OpenAlex ID | https://openalex.org/W2575565717 |
| PMID | 28103612 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Qing Zhou](https://scholariq.org/researchers/qing-zhou/)
- [Xiaoyan Bai](https://scholariq.org/researchers/xiaoyan-bai/)
- [Yi‐Long Wu](https://scholariq.org/researchers/yi-long-wu/)

## Paper journal

- [British Journal of Cancer](https://scholariq.org/journals/british-journal-of-cancer/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.